Triazine Compounds as PI3 Kinase and Mtor Inhibitors

Wyeth, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 61/055,661, filed May 23, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 8,217,036	Triazine Compounds as PI3 Kinase and Mtor Inhibitors Wyeth LLC In force Term ends May 22, 2029 · High confidence	Wyeth LLC	In force	Term ends May 22, 2029	Term ends May 22, 2029	High confidence
US 8,445,486	Triazine Compounds as PI3 Kinase and Mtor Inhibitors Wyeth LLC In force Term ends May 22, 2029 · High confidence	Wyeth LLC	In force	Term ends May 22, 2029	Term ends May 22, 2029	High confidence
US 8,575,159	Triazine Compounds as PI3 Kinase and Mtor Inhibitors Wyeth LLC In force Term ends May 22, 2029 · High confidence	Wyeth LLC	In force	Term ends May 22, 2029	Term ends May 22, 2029	High confidence
US 8,748,421	Triazine Compounds as PI3 Kinase and Mtor Inhibitors Wyeth LLC In force Term ends May 22, 2029 · High confidence	Wyeth LLC	In force	Term ends May 22, 2029	Term ends May 22, 2029	High confidence
US 8,859,542	Triazine Compounds as PI3 Kinase and Mtor Inhibitors Wyeth LLC In force Term ends May 22, 2029 · High confidence	Wyeth LLC	In force	Term ends May 22, 2029	Term ends May 22, 2029	High confidence
US 9,174,963	Triazine Compounds as PI3 Kinase and Mtor Inhibitors Wyeth LLC In force Term ends May 22, 2029 · High confidence	Wyeth LLC	In force	Term ends May 22, 2029	Term ends May 22, 2029	High confidence
US 10,022,381	Triazine Compounds as PI3 Kinase and Mtor Inhibitors Wyeth LLC In force Ends no later than May 22, 2029 · Medium confidence	Wyeth LLC	In force	Ends no later than May 22, 2029	Ends no later than May 22, 2029	Medium confidence
US 8,039,469	Triazine Compounds as PI3 Kinase and Mtor Inhibitors Wyeth LLC In force Term ends Dec 17, 2029 · High confidence	Wyeth LLC	In force	Term ends Dec 17, 2029	Term ends Dec 17, 2029	High confidence

8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.